1. Home
  2. WHD vs IOVA Comparison

WHD vs IOVA Comparison

Compare WHD & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cactus Inc.

WHD

Cactus Inc.

HOLD

Current Price

$46.68

Market Cap

3.4B

Sector

Industrials

ML Signal

HOLD

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$3.33

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WHD
IOVA
Founded
2011
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
1.4B
IPO Year
2018
2008

Fundamental Metrics

Financial Performance
Metric
WHD
IOVA
Price
$46.68
$3.33
Analyst Decision
Buy
Buy
Analyst Count
6
10
Target Price
$56.33
$9.11
AVG Volume (30 Days)
1.1M
15.6M
Earning Date
04-29-2026
05-07-2026
Dividend Yield
1.16%
N/A
EPS Growth
18.99
14.84
EPS
0.19
N/A
Revenue
$1,079,051,000.00
N/A
Revenue This Year
$44.76
$51.55
Revenue Next Year
$5.51
$37.55
P/E Ratio
$254.16
N/A
Revenue Growth
N/A
N/A
52 Week Low
$33.30
$1.64
52 Week High
$59.25
$5.63

Technical Indicators

Market Signals
Indicator
WHD
IOVA
Relative Strength Index (RSI) 40.25 41.08
Support Level $43.47 $2.02
Resistance Level $47.95 $4.34
Average True Range (ATR) 1.57 0.33
MACD 0.29 -0.14
Stochastic Oscillator 44.86 2.86

Price Performance

Historical Comparison
WHD
IOVA

About WHD Cactus Inc.

Cactus Inc is engaged in the designing, manufacturing, and sale of wellheads and pressure control equipment. Its principal products include Cactus SafeDrill wellhead systems, conventional wellheads, and production valves among others. The company also provides mission-critical field services, including service crews to assist with the installation, maintenance, and safe handling of the wellhead and pressure control equipment, as well as repair services for equipment that it sells or rents. It sells or rents its products principally for onshore unconventional oil and gas wells that are utilized during the drilling, completion (including fracturing), and production. It has two operating segments; Pressure Control, which generates key revenue and Spoolable Technologies.

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

Share on Social Networks: